Register to chat with like-minded investors on our interactive forums.
The current KNB market cap is 5.85M. The company's latest EPS is GBP -0.0126 and P/E is -0.73.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 73k | 603k | 895k |
| Operating Income | -365k | -156k | -3.93M | -6.5M | -7.88M |
| Net Income | -363k | -131k | -4.55M | -6.87M | -7.99M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 710k | 792k | 5.6M | 14.45M | 8.35M |
| Total Liabilities | 36k | 54k | 415k | 2.01M | 849k |
| Total Equity | 674k | 738k | 5.18M | 12.45M | 7.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -346k | -100k | -2.08M | -3.78M | -2.52M |
| Investing | -98k | -300k | -1.01M | 77k | -1.7M |
| Financing | N/A | 162k | 7.24M | 2.4M | 2.57M |
| Market Cap | 5.85M |
| Price to Earnings Ratio | -0.73 |
| Price to Sales Ratio | 6.57 |
| Price to Cash Ratio | 3.41 |
| Price to Book Ratio | 0.78 |
| Dividend Yield | - |
| Shares Outstanding | 632.43M |
| Average Volume (1 week) | 221.9k |
| Average Volume (1 Month) | 233.39k |
| 52 Week Change | -27.45% |
| 52 Week High | 3.05 |
| 52 Week Low | 0.882 |
| Spread (Intraday) | 0.15 (15%) |
| Company Name | Kanabo Group Plc |
| Address |
churchill house london NW4 4DJ |
| Website | https://www.kanabogroup.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
